vs
Douglas Elliman Inc.（DOUG）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Douglas Elliman Inc.的季度营收约是Ultragenyx Pharmaceutical Inc.的1.2倍（$245.4M vs $207.3M），Douglas Elliman Inc.净利率更高（27.9% vs -62.0%，领先90.0%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 0.9%），Douglas Elliman Inc.自由现金流更多（$-14.7M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 10.7%）
Douglas Elliman Inc.是美国领先的住宅房地产经纪企业，提供高端房产买卖、租赁、物业管理及相关咨询服务，核心业务覆盖纽约、加州、佛罗里达、得克萨斯等都会区，主要服务高净值客户群体。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
DOUG vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $245.4M | $207.3M |
| 净利润 | $68.6M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | 27.3% | -54.7% |
| 净利率 | 27.9% | -62.0% |
| 营收同比 | 0.9% | 25.9% |
| 净利润同比 | 1243.4% | 3.5% |
| 每股收益（稀释后） | $0.80 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $245.4M | $207.3M | ||
| Q3 25 | $262.8M | $159.9M | ||
| Q2 25 | $271.4M | $166.5M | ||
| Q1 25 | $253.4M | $139.3M | ||
| Q4 24 | $243.3M | $164.6M | ||
| Q3 24 | $266.3M | $139.5M | ||
| Q2 24 | $285.8M | $147.0M | ||
| Q1 24 | $200.2M | $108.8M |
| Q4 25 | $68.6M | $-128.6M | ||
| Q3 25 | $-24.7M | $-180.4M | ||
| Q2 25 | $-22.7M | $-115.0M | ||
| Q1 25 | $-6.0M | $-151.1M | ||
| Q4 24 | $-6.0M | $-133.2M | ||
| Q3 24 | $-27.2M | $-133.5M | ||
| Q2 24 | $-1.7M | $-131.6M | ||
| Q1 24 | $-41.5M | $-170.7M |
| Q4 25 | 27.3% | -54.7% | ||
| Q3 25 | -4.1% | -106.9% | ||
| Q2 25 | -2.0% | -64.8% | ||
| Q1 25 | -2.1% | -102.6% | ||
| Q4 24 | -6.7% | -74.3% | ||
| Q3 24 | -2.8% | -94.6% | ||
| Q2 24 | -1.3% | -79.1% | ||
| Q1 24 | -20.7% | -151.9% |
| Q4 25 | 27.9% | -62.0% | ||
| Q3 25 | -9.4% | -112.8% | ||
| Q2 25 | -8.4% | -69.0% | ||
| Q1 25 | -2.4% | -108.5% | ||
| Q4 24 | -2.5% | -80.9% | ||
| Q3 24 | -10.2% | -95.7% | ||
| Q2 24 | -0.6% | -89.5% | ||
| Q1 24 | -20.7% | -156.8% |
| Q4 25 | $0.80 | $-1.28 | ||
| Q3 25 | $-0.29 | $-1.81 | ||
| Q2 25 | $-0.27 | $-1.17 | ||
| Q1 25 | $-0.07 | $-1.57 | ||
| Q4 24 | $-0.06 | $-1.34 | ||
| Q3 24 | $-0.33 | $-1.40 | ||
| Q2 24 | $-0.02 | $-1.52 | ||
| Q1 24 | $-0.50 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $115.5M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $183.9M | $-80.0M |
| 总资产 | $444.4M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $115.5M | $421.0M | ||
| Q3 25 | $143.0M | $202.5M | ||
| Q2 25 | $136.3M | $176.3M | ||
| Q1 25 | $136.8M | $127.1M | ||
| Q4 24 | $145.5M | $174.0M | ||
| Q3 24 | $151.4M | $150.6M | ||
| Q2 24 | $92.9M | $480.7M | ||
| Q1 24 | $91.5M | $112.3M |
| Q4 25 | $183.9M | $-80.0M | ||
| Q3 25 | $115.1M | $9.2M | ||
| Q2 25 | $137.6M | $151.3M | ||
| Q1 25 | $158.2M | $144.2M | ||
| Q4 24 | $162.2M | $255.0M | ||
| Q3 24 | $173.6M | $346.8M | ||
| Q2 24 | $196.9M | $432.4M | ||
| Q1 24 | $195.1M | $140.3M |
| Q4 25 | $444.4M | $1.5B | ||
| Q3 25 | $480.6M | $1.2B | ||
| Q2 25 | $489.0M | $1.3B | ||
| Q1 25 | $493.9M | $1.3B | ||
| Q4 24 | $493.9M | $1.5B | ||
| Q3 24 | $502.7M | $1.5B | ||
| Q2 24 | $463.9M | $1.6B | ||
| Q1 24 | $461.1M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.4M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $-14.7M | $-100.8M |
| 自由现金流率自由现金流/营收 | -6.0% | -48.6% |
| 资本支出强度资本支出/营收 | 0.1% | 0.5% |
| 现金转化率经营现金流/净利润 | -0.21× | — |
| 过去12个月自由现金流最近4个季度 | $-17.2M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $-14.4M | $-99.8M | ||
| Q3 25 | $5.5M | $-91.4M | ||
| Q2 25 | $642.0K | $-108.3M | ||
| Q1 25 | $-5.6M | $-166.5M | ||
| Q4 24 | $-9.0M | $-79.3M | ||
| Q3 24 | $9.0M | $-67.0M | ||
| Q2 24 | $1.3M | $-77.0M | ||
| Q1 24 | $-27.3M | $-190.7M |
| Q4 25 | $-14.7M | $-100.8M | ||
| Q3 25 | $4.7M | $-92.7M | ||
| Q2 25 | $-575.0K | $-110.7M | ||
| Q1 25 | $-6.7M | $-167.8M | ||
| Q4 24 | $-10.2M | $-79.5M | ||
| Q3 24 | $7.7M | $-68.6M | ||
| Q2 24 | $432.0K | $-79.0M | ||
| Q1 24 | $-29.4M | $-193.9M |
| Q4 25 | -6.0% | -48.6% | ||
| Q3 25 | 1.8% | -58.0% | ||
| Q2 25 | -0.2% | -66.5% | ||
| Q1 25 | -2.6% | -120.5% | ||
| Q4 24 | -4.2% | -48.3% | ||
| Q3 24 | 2.9% | -49.2% | ||
| Q2 24 | 0.2% | -53.7% | ||
| Q1 24 | -14.7% | -178.2% |
| Q4 25 | 0.1% | 0.5% | ||
| Q3 25 | 0.3% | 0.8% | ||
| Q2 25 | 0.4% | 1.5% | ||
| Q1 25 | 0.4% | 1.0% | ||
| Q4 24 | 0.5% | 0.1% | ||
| Q3 24 | 0.5% | 1.2% | ||
| Q2 24 | 0.3% | 1.4% | ||
| Q1 24 | 1.0% | 3.0% |
| Q4 25 | -0.21× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOUG
| Commissions And Other Brokerage Income | $240.3M | 98% |
| Property Management Income | $2.8M | 1% |
| Property Management | $2.2M | 1% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
